Warby Parker Inc. WRBY
4 trading plans running, 33 Form 144 notices for $59.2M
10-Q, 10-K and Form 144What WRBY's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Sep 13, 2024 to Jun 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Dave Gilboa Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Aug 19, 2026 | 10-Q Nov 5, 2026 | ||
What the company wroteOn August 19, 2026, Dave Gilboa, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 2,064,191 shares of our Class A common stock. The trading arrangement will expire on June 30, 2027 or earlier if all transactions under the trading arrangement are completed. | |||||
| Neil Blumenthal Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Aug 18, 2026 | 10-Q Nov 5, 2026 | ||
What the company wroteOn August 18, 2026, Neil Blumenthal, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 750,000 shares of our Class A common stock. The trading arrangement will expire on June 30, 2027 or earlier if all transactions under the trading arrangement are completed. | |||||
| Dave Gilboa Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Mar 17, 2026 | 10-Q May 7, 2026 | ||
What the company wroteOn March 17, 2026, Dave Gilboa, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,945,492 shares of our Class A common stock. The trading arrangement will expire on December 31, 2026 or earlier if all transactions under the trading arrangement are completed. | |||||
| Neil Blumenthal Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Mar 17, 2026 | 10-Q May 7, 2026 | ||
What the company wroteOn March 17, 2026, Neil Blumenthal, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,500,000 shares of our Class A common stock. The trading arrangement will expire on December 31, 2026 or earlier if all transactions under the trading arrangement are completed. | |||||
| Teresa Briggs director |
Adopted 10b5-1 plan | Mar 17, 2026 | 10-Q May 7, 2026 | ||
What the company wroteOn March 17, 2026, Teresa Briggs, a director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 5,000 shares of our Class A common stock. The trading arrangement will expire on June 20, 2026 or earlier if all transactions under the trading arrangement are completed. | |||||
| Dave Gilboa Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Sep 16, 2025 | 10-Q Nov 6, 2025 | ||
What the company wroteOn September 16, 2025, Dave Gilboa, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,000,000 shares of our Class A common stock. The trading arrangement will expire on June 30, 2026 or earlier if all transactions under the trading arrangement are completed. | |||||
| Neil Blumenthal Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Sep 16, 2025 | 10-Q Nov 6, 2025 | ||
What the company wroteOn September 16, 2025, Neil Blumenthal, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,600,000 shares of our Class A common stock. The trading arrangement will expire on June 30, 2026 or earlier if all transactions under the trading arrangement are completed. | |||||
| Dave Gilboa Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Mar 14, 2025 | 10-Q May 8, 2025 | ||
What the company wroteOn March 14, 2025, Dave Gilboa, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,050,000 shares of our Class A common stock. The trading arrangement will expire on December 31, 2025 or earlier if all transactions under the trading arrangement are completed. | |||||
| Neil Blumenthal Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Mar 14, 2025 | 10-Q May 8, 2025 | ||
What the company wroteOn March 14, 2025, Neil Blumenthal, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,100,000 shares of our Class A common stock. The trading arrangement will expire on December 31, 2025 or earlier if all transactions under the trading arrangement are completed. | |||||
| Dave Gilboa Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Sep 13, 2024 | 10-Q Nov 7, 2024 | ||
What the company wroteOn September 13, 2024, Dave Gilboa, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 950,000 shares of our Class A common stock. The trading arrangement will expire on June 30, 2025 or earlier if all transactions under the trading arrangement are completed. | |||||
| Neil Blumenthal Co-Chief Executive Officer and director |
Adopted 10b5-1 plan | Sep 13, 2024 | 10-Q Nov 7, 2024 | ||
What the company wroteOn September 13, 2024, Neil Blumenthal, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,250,000 shares of our Class A common stock. The trading arrangement will expire on June 30, 2025 or earlier if all transactions under the trading arrangement are completed. | |||||
| Teresa Briggs member of our board of directors |
Adopted 10b5-1 plan | Mar 14, 2024 | 10-Q May 9, 2024 | ||
What the company wroteOn March 14, 2024, Teresa Briggs, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading arrangement provides for the sale of 50% of the number of shares of our Class A common stock to be received as fully vested RSUs following our 2024 annual meeting of stockholders pursuant to our Director Compensation Program. The aggregate number of shares sold under the trading arrangement will depend on the average closing trading price of our Class A common stock over the 30-day period ending the day prior to the date of such annual meeting. The trading arrangement will expire on December 31, 2024 or earlier if all transactions under the trading arrangement are completed. | |||||
| Dave Gilboa Co-Chief Executive Officer and director |
Adopted plan | Nov 22, 2023 | 10-K Feb 29, 2024 | ||
What the company wroteOn November 22, 2023, Dave Gilboa, our Co-Chief Executive Officer and director, modified a Rule 10b5-1 trading arrangement originally adopted on September 14, 2023. The modified trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) and provides for the sale of up to an aggregate of 1,209,080 shares of our Class A common stock. The modified trading arrangement will expire on December 31, 2024 or earlier if all transactions under the trading arrangement are completed. | |||||
| Dave Gilboa Co-Chief Executive Officer and director |
Adopted other arrangement | Sep 14, 2023 | 10-Q Nov 8, 2023 | ||
What the company wroteOn September 14, 2023, Dave Gilboa, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 1,209,080 shares of our Class A common stock. The trading arrangement will expire on December 31, 2024 or earlier if all transactions under the trading arrangement are completed. | |||||
| Neil Blumenthal Co-Chief Executive Officer and director |
Adopted other arrangement | Sep 14, 2023 | 10-Q Nov 8, 2023 | ||
What the company wroteOn September 14, 2023, Neil Blumenthal, our Co-Chief Executive Officer and director, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 950,000 shares of our Class A common stock. The trading arrangement will expire on December 31, 2024 or earlier if all transactions under the trading arrangement are completed. | |||||
| Steve Miller Chief Financial Officer, |
Adopted other arrangement | Aug 29, 2023 | 10-Q Nov 8, 2023 | ||
What the company wroteOn August 29, 2023, Steve Miller, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) providing for the sale of up to an aggregate of 112,461 shares of our Class A common stock. The aggregate number of shares sold under the plan may differ based on tax withholdings for vesting stock awards. The trading arrangement will expire on December 31, 2024 or earlier if all transactions under the trading arrangement are completed. | |||||
Show the other 8 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 9, 2026 | DAVID GILBOA Director, Officer |
75,402 | $1.9M |
| Nov 9, 2026 | NEIL BLUMENTHAL Director, Officer |
73,133 | $1.9M |
| Nov 9, 2026 | JEFFREY RAIDER Director |
30,000 | $764K |
| Oct 1, 2026 | JEFFREY RAIDER Director |
15,000 | $417K |
| Oct 1, 2026 | NEIL BLUMENTHAL Director, Officer |
100,000 | $2.8M |
| Jul 6, 2026 | NEIL BLUMENTHAL Director, Officer |
9,200 | $269K |
| Jul 6, 2026 | DAVID GILBOA Director, Officer |
54,347 | $1.6M |
| Jul 1, 2026 | NEIL BLUMENTHAL Director, Officer |
217,667 | $6.6M |
| Jul 1, 2026 | DAVID GILBOA Director, Officer |
242,221 | $7.3M |
| Jul 1, 2026 | JEFFREY RAIDER Director |
22,500 | $683K |
| Jun 29, 2026 | NEIL BLUMENTHAL Director, Officer |
36,300 | $1.1M |
| Jun 16, 2026 | TERESA BRIGGS Director |
5,000 | $132K |
| Jun 12, 2026 | YOUNGME MOON Director |
10,000 | $265K |
| May 19, 2026 | NEIL BLUMENTHAL Director, Officer |
63,040 | $1.8M |
| May 13, 2026 | Bradley Singer Director |
25,000 | $674K |
| Apr 17, 2026 | NEIL BLUMENTHAL Director, Officer |
50,000 | $1.2M |
| Apr 16, 2026 | NEIL BLUMENTHAL Director, Officer |
50,000 | $1.2M |
| Mar 11, 2026 | JEFFREY RAIDER Director |
25,000 | $636K |
| Mar 4, 2026 | BRADLEY SINGER Director |
15,793 | $435K |
| Jan 13, 2026 | DAVID GILBOA Director, Officer |
80,094 | $2.1M |
| Jan 13, 2026 | NEIL BLUMENTHAL Director, Officer |
660 | $18K |
| Jan 9, 2026 | DAVID GILBOA Director, Officer |
19,906 | $563K |
| Jan 7, 2026 | NEIL BLUMENTHAL Director, Officer |
50,000 | $1.3M |
| Jan 7, 2026 | DAVID GILBOA Director, Officer |
75,000 | $1.9M |
| Jan 6, 2026 | NEIL BLUMENTHAL Director, Officer |
150,000 | $3.5M |
| Jan 6, 2026 | DAVID GILBOA Director, Officer |
50,000 | $1.2M |
| Jan 2, 2026 | DAVID GILBOA Director, Officer |
25,000 | $545K |
| Dec 16, 2025 | Joel Cutler Director |
32,249 | $859K |
| Dec 15, 2025 | Warby Parker Impact Foundation 10% Stockholder |
178,572 | $4.9M |
| Dec 12, 2025 | JEFFREY RAIDER Officer |
25,000 | $686K |
| Dec 11, 2025 | David Gilboa Director, Officer |
200,000 | $5.9M |
| Dec 11, 2025 | NEIL BLUMENTHAL Director, Officer |
100,000 | $3.0M |
| Dec 11, 2025 | YOUNGME MOON Director |
38,832 | $1.1M |
Show the other 25 notices
From the Form 144 XML filed with the SEC, since Dec 11, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/WRBY/export.csv") into a cell.